Company: BIAF
Filing Date: 2025-02-27
Form Type: 8-K
Source: 0001493152-25-008471
Chunk: 4

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-02-27
Form: 8-K
Item: Item 1.01
Chunk 4
---
 Common Stock, including any voting rights, until the holder exercises
such warrant.

The
New Warrants and the New Warrant Shares described herein are being issued in a private placement and have not been registered under the
Securities Act of 1933, as amended (the “ Securities Act”), and are instead being offered pursuant to the exemption provided
in Section 4(a)(2) under the Securities Act and Rule 506(b) promulgated thereunder.

The
foregoing summaries of each of the New Warrants, the Advisor Warrants and the Inducement Agreement,
do not purport to be complete and are qualified in their entirety by reference to the definitive transaction documents, copies of which
are attached hereto as Exhibits 4.1, 4.2, and 10.1, respectively, and are each incorporated herein by reference.

The
Company notes that the representations, warranties and covenants made by the Company in any agreement that is incorporated by reference
herein were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk
among the parties to such agreements. In addition, the assertions embodied in any representations, warranties and covenants contained
in such agreements may be subject to qualifications with respect to knowledge and materiality different from those applicable to security
holders generally. Moreover, such representations, warranties or covenants were accurate only as of the date when made, except where
expressly stated otherwise. Accordingly, such representations, warranties and covenants should not be relied on as accurately representing
the current state of the Company’s affairs at any time.

This
Current Report on Form 8-K does not constitute an offer to sell or the solicitation of an offer to buy, and these securities cannot be
sold in any state or jurisdiction in which this offer, solicitation, or sale would be unlawful prior to registration or qualification
under the securities laws of any state or jurisdiction. Any offer will be made only by means of a prospectus, including a prospectus
supplement, forming a part of the effective registration statement.